European Journal of Cancer
Volume 43, Issue 15 , Pages 2235-2241, October 2007

Mastering chemotherapy dose reduction in elderly cancer patients

Department of General Medical Oncology/Multidisciplinary Breast Centre, University Hospital Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium

Received 9 March 2007; received in revised form 25 June 2007; accepted 27 June 2007. published online 08 August 2007.

Abstract 

Cancer is mainly a disease of the elderly but clinical studies have generally excluded the elderly population for various reasons. Chemotherapy is one of the strongest weapons against (metastatic) cancer, but its use in the elderly has been limited due to fear of inducing toxicity. This review points out 10 recommendations that need to be taken into account when prescribing chemotherapy to elderly patients: aim of chemotherapy, specific pharmacological data for specific chemotherapeutics, treatment individualisation, alternatives to cytotoxic chemotherapy, comprehensive geriatric assessment, supportive therapy, hydration status, drug interactions, and compliance. Each of these topics will be reviewed here trying to give concrete recommendations for clinical practice.

Keywords: Cancer, Chemotherapy, Elderly, Dose reduction, Pharmacology

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0959-8049(07)00511-4

doi:10.1016/j.ejca.2007.06.013

European Journal of Cancer
Volume 43, Issue 15 , Pages 2235-2241, October 2007

Article Tools